Journal: Nutrition Research and Practice
Article Title: Modulatory effects of Hizikia fusiformis on the dopaminergic system in a neonatal habenular lesion-induced attention-deficit hyperactivity disorder-like rodent model
doi: 10.4162/nrp.2026.20.1.31
Figure Lengend Snippet: (A) The bar graph indicates the percentage of VEH in HF-induced MAP2 expression. (B, C) These bar graphs are similar to graph (A); however, they show the expression of NF (B) and SYP (C). Protein expression was analyzed using analysis of variance and Bonferroni post-hoc test. Statistical significance was set at P < 0.05. HF, Hizikia fusiformis ; MAP2, microtubule-associated protein 2; NF, neurofilament; SYP, synaptophysin; VEH, vehicle.
Article Snippet: The following were the primary antibodies used: mouse monoclonal anti-synaptophysin (SYP; catalog #: S5768; Sigma-Aldrich), rabbit polyclonal anti-tyrosine hydroxylase (TH; catalog #: E-AB-33093; Elabscience, Houston, TX, USA), mouse monoclonal neurofilament (NF; catalog #: sc-20012; Santa Cruz Biotechnology, Dallas, TX, USA), rabbit polyclonal anti-DAT (catalog #: PA1-4656; Invitrogen, Waltham, MA, USA), mouse monoclonal anti-DRD2 (catalog #: sc-5303; Santa Cruz Biotechnology), rabbit polyclonal anti-DRD1 (catalog #: E-AB-31152; Elabscience), mouse monoclonal anti-DRD3 (catalog #: sc-136170; Santa Cruz Biotechnology), rabbit polyclonal anti-DRD5 (catalog #: MBS2516950; MyBioSource, San Diego, CA, USA), mouse monoclonal anti-microtubule-associated protein 2 (MAP2; catalog #: sc-32791; Santa Cruz Biotechnology), and rabbit polyclonal anti-DRD4 (catalog #: E-AB-31153; Elabscience).
Techniques: Expressing